<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02279225</url>
  </required_header>
  <id_info>
    <org_study_id>y4tma2ef</org_study_id>
    <nct_id>NCT02279225</nct_id>
  </id_info>
  <brief_title>Protocol Phototherapy Treatment for Fibromyalgia and Temporomandibular Joint Dysfunction</brief_title>
  <acronym>FM and DTM</acronym>
  <official_title>RANDOMIZED DOUBLE-BLIND CONTROLLED THE USE OF PHOTOTHERAPY IN FIBROMIÁLGICOS WITH TEMPOROMANDIBULAR JOINT DYSFUNCTION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nove de Julho</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nove de Julho</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Temporomandibular joint dysfunction is described as a multifactorial disease and can be&#xD;
      directly linked to other diseases, being of structural factors of the Stomatognathic System&#xD;
      or not, such as fibromyalgia. Studies show the interconnection of Temporomandibular&#xD;
      Dysfunctions with fibromyalgia. Thus, this project aims to evaluate the effect of&#xD;
      Phototherapy on fibromiálgicos patients with temporomandibular dysfunction This is a&#xD;
      Randomized, Controlled and double-blind, with the intention to treat. In this way the sample&#xD;
      of 61 patients with Fibromyalgia, Temporomandibular joint Dysfunction associated with ages&#xD;
      between 35 to 58 years, females who are selected after the inclusion/exclusion criteria, will&#xD;
      be randomly distributed in homogeneous groups and the placebo group (P), Phototherapy (FT)&#xD;
      group, group of physical activity (A) aerobic and aerobic physical activity + Phototherapy&#xD;
      Group (FT + A). Will be used as a means of analysis before and after interventions the&#xD;
      following parameters: Pain: clinical evaluation, evaluation of pain by Visual analog scale of&#xD;
      pain (EVA), McGill Pain Questionnarire and pressure Algometria. Still we will evaluate the&#xD;
      dosage of serotonin, indirectly, by saliva. Quality of life: own illness as questionnaires&#xD;
      FIQ (Fibromyalgia Impact Questionnaire), Medical Outcomes Study 36-item Short-Form Health&#xD;
      Survey SF-36 and also will assess the quality of sleep, with polysomnography. The treatments&#xD;
      will total in 10 sessions held twice a week, and the FT and FT + groups to receive&#xD;
      Phototherapy enforcement will be used a portable cluster 9 diodes, where will be delivered&#xD;
      39.3 Joules in tender points of fibromyalgia and TMJ, groups and FT + to carry out aerobic&#xD;
      activity in 75% of your MHR for 50 min and the P group will receive the application of&#xD;
      Phototherapy of 0 Joules (IE, the equipment does not emit any power). Statistical analysis&#xD;
      will be compared using the t test intra-group-Student, one-tail and paired and can be used&#xD;
      the Kruskal-Wallis test, the statistical analysis of significance 0.05 for both tests.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>10 sessions, in 5 weeks, 2 times a week</time_frame>
    <description>The time corresponds to assess changes: Assessed on the first day before the start of the first session and the reassessment is made after the last session, after half an hour of intervention. Assessed with questionnaires, and EVA, and algometry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of sleep</measure>
    <time_frame>before and after: 10 sessions in 5 weeks, 2 times a week</time_frame>
    <description>The time corresponds to assess changes: Performs initial assessment a week before the first session and the revaluation performs after a week of the last session. evaluation with polysomnography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>10 sessions, in 5 weeks, 2 times a week</time_frame>
    <description>The time corresponds to assess changes: Assessed on the first day before the start of the first session and the reassessment is made after the last session, after half an hour of intervention. Assessed with questionnaires.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">61</enrollment>
  <condition>Pain</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>placebo (P)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention without radiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phototherapy (FT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention only with phototherapy radiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phototherapy+Physical activity (FT+A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention associated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity (A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention with physical activity: the gold standard of treatment in fibromyalgia</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Group Phototherapy</intervention_name>
    <arm_group_label>phototherapy (FT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Phototherapy + Physical activity</intervention_name>
    <arm_group_label>phototherapy+Physical activity (FT+A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical activity</intervention_name>
    <arm_group_label>Physical activity (A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>placebo (P)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of Fibromyalgia according to the criteria of the American College&#xD;
             of Rheumatology;&#xD;
&#xD;
               -  Clinical diagnosis of TMD by the RDC questionnaire (annex I);&#xD;
&#xD;
               -  Cognitive Level enough to understand the procedures and follow the guidelines&#xD;
                  that will be passed;&#xD;
&#xD;
               -  People who use drugs corresponding to Fibromyalgia (FM), antidepressant;&#xD;
&#xD;
               -  Class I of angle&#xD;
&#xD;
               -  Consent to participate in the study and sign the consent form post information.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  With psychiatric disorders;&#xD;
&#xD;
          -  Cognitive Changes;&#xD;
&#xD;
          -  People who perform some exercise;&#xD;
&#xD;
          -  People who carry out orthodontic treatment;&#xD;
&#xD;
          -  Systemic diseases;&#xD;
&#xD;
          -  Persons under the age of 35 and more than 58 years.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>58 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mariana Moreira da Silva55011</last_name>
    <phone>55 011 992248813</phone>
    <email>fisioterapeutamariana@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mariana Moreira Da Silva</name>
      <address>
        <city>São Caetano do Sul</city>
        <state>SP</state>
        <zip>09560500</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MARIANA MOREIRA D SILVA</last_name>
      <phone>+5511992248813</phone>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <study_first_submitted>October 14, 2014</study_first_submitted>
  <study_first_submitted_qc>October 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2014</study_first_posted>
  <last_update_submitted>December 13, 2015</last_update_submitted>
  <last_update_submitted_qc>December 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nove de Julho</investigator_affiliation>
    <investigator_full_name>Mariana Moreira da Silva</investigator_full_name>
    <investigator_title>RANDOMIZED DOUBLE-BLIND CONTROLLED THE USE OF PHOTOTHERAPY IN FIBROMIÁLGICOS WITH TEMPOROMANDIBULAR JOINT DYSFUNCTION</investigator_title>
  </responsible_party>
  <keyword>Phototherapy</keyword>
  <keyword>Laser</keyword>
  <keyword>Fibromyalgia</keyword>
  <keyword>DTM/ TMD</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

